{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:22:29Z","timestamp":1787790149578,"version":"build-2784847793"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-57284-w","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T02:21:30Z","timestamp":1780971690000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of risk assessment models for microvascular complications in type 2 diabetes mellitus patients: a cross-sectional study"],"prefix":"10.1038","volume":"16","author":[{"given":"Yuhan","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenrun","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiebin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalong","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjie","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"57284_CR1","doi-asserted-by":"publisher","first-page":"3483","DOI":"10.2147\/DMSO.S387040","volume":"15","author":"H Yao","year":"2022","unstructured":"Yao, H. et al. Relationship between the triglyceride-glucose index and type 2 diabetic macroangiopathy: A single-center retrospective analysis. Diabetes Metab. Syndr. Obes.: Targets Ther. 15, 3483\u20133497 (2022).","journal-title":"Diabetes metabolic syndrome obesity: targets therapy"},{"issue":"1","key":"57284_CR2","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes, J. M. & Cooper, M. E. Mechanisms of diabetic complications. Physiol. Rev. 93(1), 137\u2013188 (2013).","journal-title":"Physiol. Rev."},{"issue":"19","key":"57284_CR3","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1001\/jama.287.19.2570","volume":"287","author":"JA Beckman","year":"2002","unstructured":"Beckman, J. A., Creager, M. A. & Libby, P. Diabetes and atherosclerosis: Epidemiology, pathophysiology, and management. JAMA 287(19), 2570\u20132581 (2002).","journal-title":"JAMA"},{"issue":"1","key":"57284_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/aos.14487","volume":"99","author":"YT Hsieh","year":"2021","unstructured":"Hsieh, Y. T. & Hsieh, M. C. Time-sequential correlations between diabetic kidney disease and diabetic retinopathy in type 2 diabetes-an 8-year prospective cohort study. Acta Ophthalmol. 99(1), e1\u2013e6 (2021).","journal-title":"Acta Ophthalmol."},{"issue":"9","key":"57284_CR5","doi-asserted-by":"publisher","first-page":"e240124225997","DOI":"10.2174\/0115733998274599231109034741","volume":"20","author":"A Kaur","year":"2024","unstructured":"Kaur, A., Kumar, R. & Sharma, A. Diabetic retinopathy leading to blindness\u2014a review. Curr. Diabetes Rev. 20(9), e240124225997 (2024).","journal-title":"Curr. Diabetes Rev."},{"key":"57284_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/dom.14007","volume":"22","author":"NM Selby","year":"2020","unstructured":"Selby, N. M. & Taal, M. W. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes. Metab. 22, 3\u201315 (2020).","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"57284_CR7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.2040-1124.2011.00131.x","volume":"2","author":"Z Cao","year":"2011","unstructured":"Cao, Z. & Cooper, M. E. Pathogenesis of diabetic nephropathy. J. Diabetes Invest. 2(4), 243\u2013247 (2011).","journal-title":"J. Diabetes Invest."},{"issue":"6","key":"57284_CR8","first-page":"956","volume":"40","author":"X Xia","year":"2020","unstructured":"Xia, X. et al. Effect of Cyclocarya paliurus polysaccharides on streptozotocin-induced diabetic nephropathy in rats. J. traditional Chin. Med. = Chung i tsa chih ying wen pan. 40(6), 956\u2013964 (2020).","journal-title":"J. traditional Chin. Med. = Chung i tsa chih ying wen pan"},{"issue":"11","key":"57284_CR9","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s10147-019-01489-9","volume":"24","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Development and validation of a nomogram containing the prognostic determinants of chondrosarcoma based on the surveillance, epidemiology, and end results database. Int. J. Clin. Oncol. 24(11), 1459\u20131467 (2019).","journal-title":"Int. J. Clin. Oncol."},{"issue":"7","key":"57284_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cac2.12067","volume":"40","author":"J Wu","year":"2020","unstructured":"Wu, J. et al. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun. (London England). 40(7), 301\u2013312 (2020).","journal-title":"Cancer Commun. (London England)"},{"issue":"3","key":"57284_CR11","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1016\/S2589-7500(21)00006-6","volume":"3","author":"DR Hess","year":"2021","unstructured":"Hess, D. R. A nomogram for use of non-invasive respiratory strategies in COVID-19. Lancet Digit. health. 3(3), e140\u2013e141 (2021).","journal-title":"Lancet Digit. health"},{"issue":"1","key":"57284_CR12","first-page":"12","volume":"61","author":"[Clinical guidelines for prevention","year":"2022","unstructured":"[Clinical guidelines for prevention. and treatment of type 2 diabetes mellitus in the elderly in China (2022 edition)]. Zhonghua nei ke za zhi. 61(1), 12\u201350 (2022).","journal-title":"Zhonghua nei ke za zhi"},{"issue":"1","key":"57284_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.tcm.2020.10.001","volume":"31","author":"R Citro","year":"2021","unstructured":"Citro, R. et al. Role of multimodality imaging in evaluation of cardiovascular involvement in COVID-19. Trends Cardiovasc. Med. 31(1), 8\u201316 (2021).","journal-title":"Trends Cardiovasc. Med."},{"issue":"6","key":"57284_CR14","doi-asserted-by":"publisher","first-page":"101427","DOI":"10.1016\/j.jbc.2021.101427","volume":"297","author":"H Ito","year":"2021","unstructured":"Ito, H. et al. The synaptic scaffolding protein CNKSR2 interacts with CYTH2 to mediate hippocampal granule cell development. J. Biol. Chem. 297(6), 101427 (2021).","journal-title":"J. Biol. Chem."},{"issue":"5a","key":"57284_CR15","doi-asserted-by":"publisher","first-page":"39f","DOI":"10.1016\/j.amjcard.2005.06.025","volume":"96","author":"PS Sever","year":"2005","unstructured":"Sever, P. S. et al. Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian cardiac outcomes trial-lipid-lowering arm (ASCOT-LLA). Am. J. Cardiol. 96(5a), 39f\u201344f (2005).","journal-title":"Am. J. Cardiol."},{"issue":"11","key":"57284_CR16","doi-asserted-by":"publisher","first-page":"e0225253","DOI":"10.1371\/journal.pone.0225253","volume":"14","author":"A Jalali","year":"2019","unstructured":"Jalali, A. et al. Visualising statistical models using dynamic nomograms. PloS one. 14(11), e0225253 (2019).","journal-title":"PloS one"},{"issue":"4","key":"57284_CR17","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4093\/dmj.2020.0100","volume":"45","author":"B Wu","year":"2021","unstructured":"Wu, B., Niu, Z. & Hu, F. Study on risk factors of peripheral neuropathy in type 2 diabetes mellitus and establishment of prediction model. Diabetes metabolism J. 45(4), 526\u2013538 (2021).","journal-title":"Diabetes metabolism J."},{"key":"57284_CR18","doi-asserted-by":"publisher","first-page":"104901","DOI":"10.1016\/j.mvr.2026.104901","volume":"164","author":"Y Xu","year":"2026","unstructured":"Xu, Y. et al. Quantitative evaluation of retinal vascular morphology based on the human visual bionic mechanism for the evaluation of diabetic retinopathy onset. Microvasc. Res. 164, 104901 (2026).","journal-title":"Microvasc. Res."},{"issue":"4","key":"57284_CR19","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1053\/j.ajkd.2020.01.019","volume":"76","author":"B Kwan","year":"2020","unstructured":"Kwan, B. et al. Metabolomic markers of kidney function decline in patients with diabetes: Evidence from the chronic renal insufficiency cohort (CRIC) study. Am. J. Kidney Dis.: Off. J. Natl. Kidney Found. 76(4), 511\u2013520 (2020).","journal-title":"Am. J. Kidney Dis.: Off. J. Natl. Kidney Found."},{"issue":"6","key":"57284_CR20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.2337\/dc12-1120","volume":"36","author":"J Leal","year":"2013","unstructured":"Leal, J. et al. Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data. Diabetes Care 36(6), 1541\u20131546 (2013).","journal-title":"Diabetes Care"},{"issue":"8","key":"57284_CR21","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.2215\/CJN.11111016","volume":"12","author":"SM Doshi","year":"2017","unstructured":"Doshi, S. M. & Friedman, A. N. Diagnosis and management of type 2 diabetic kidney disease. Clin. J. Am. Soc. Nephrol.: CJASN. 12(8), 1366\u20131373 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol.: CJASN"},{"key":"57284_CR22","doi-asserted-by":"publisher","first-page":"1077669","DOI":"10.3389\/fendo.2022.1077669","volume":"13","author":"TE Tan","year":"2022","unstructured":"Tan, T. E. & Wong, T. Y. Diabetic retinopathy: Looking forward to 2030. Front. Endocrinol. 13, 1077669 (2022).","journal-title":"Front. Endocrinol."},{"issue":"2","key":"57284_CR23","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.dsx.2017.09.013","volume":"12","author":"YW Pai","year":"2018","unstructured":"Pai, Y. W. et al. Prevalence and biochemical risk factors of diabetic peripheral neuropathy with or without neuropathic pain in Taiwanese adults with type 2 diabetes mellitus. Diabetol. Metab. Syndr. 12(2), 111\u2013116 (2018).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"1","key":"57284_CR24","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13098-018-0309-6","volume":"10","author":"N Khawaja","year":"2018","unstructured":"Khawaja, N. et al. The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan. Diabetol. Metab. Syndr., 10(1), 8 (2018).","journal-title":"Diabetol. Metab. Syndr."},{"issue":"10204","key":"57284_CR25","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","volume":"394","author":"M Zhou","year":"2019","unstructured":"Zhou, M. et al. Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet (London England). 394(10204), 1145\u20131158 (2019).","journal-title":"Lancet (London England)"},{"issue":"10","key":"57284_CR26","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ophtha.2017.04.024","volume":"124","author":"JB Jonas","year":"2017","unstructured":"Jonas, J. B. et al. Chronic kidney disease and eye diseases: The Beijing eye study. Ophthalmology 124(10), 1566\u20131569 (2017).","journal-title":"Ophthalmology"},{"key":"57284_CR27","doi-asserted-by":"publisher","first-page":"2082940","DOI":"10.1155\/2023\/2082940","volume":"2023","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Low total testosterone levels in men with newly diagnosed early\u2010onset type 2 diabetes: A cross\u2010sectional study in China. J. Diabetes Res. 2023, 2082940 (2023).","journal-title":"J. Diabetes Res."},{"issue":"1","key":"57284_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","volume":"6","author":"N Lascar","year":"2018","unstructured":"Lascar, N. et al. Type 2 diabetes in adolescents and young adults. Lancet Diabetes Endocrinol. 6(1), 69\u201380 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"7","key":"57284_CR29","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.amjmed.2014.03.018","volume":"127","author":"JC Chan","year":"2014","unstructured":"Chan, J. C. et al. Premature mortality and comorbidities in young-onset diabetes: A 7-year prospective analysis. Am. J. Med. 127(7), 616\u2013624 (2014).","journal-title":"Am. J. Med."},{"issue":"3","key":"57284_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1586\/14779072.6.3.315","volume":"6","author":"SH Song","year":"2008","unstructured":"Song, S. H. & Hardisty, C. A. Early-onset type 2 diabetes mellitus: An increasing phenomenon of elevated cardiovascular risk. Expert Rev. Cardiovasc. Ther. 6(3), 315\u2013322 (2008).","journal-title":"Expert Rev. Cardiovasc. Ther."},{"key":"57284_CR31","doi-asserted-by":"publisher","first-page":"4034129","DOI":"10.1155\/2016\/4034129","volume":"2016","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. The association of retinopathy and plasma glucose and HbA1c: A validation of diabetes diagnostic criteria in a Chinese population. J. Diabetes Res. 2016, 4034129 (2016).","journal-title":"J. Diabetes Res."},{"issue":"1","key":"57284_CR32","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/13813450801900553","volume":"114","author":"E Chantelau","year":"2008","unstructured":"Chantelau, E., Kimmerle, R. & Meyer-Schwickerath, R. Insulin, insulin analogues and diabetic retinopathy. Arch. Physiol. Biochem. 114(1), 54\u201362 (2008).","journal-title":"Arch. Physiol. Biochem."},{"issue":"8","key":"57284_CR33","doi-asserted-by":"publisher","first-page":"e3702","DOI":"10.1002\/dmrr.3702","volume":"39","author":"W Wang","year":"2023","unstructured":"Wang, W. et al. Prevalence and risk factors of diabetic peripheral neuropathy: A population-based cross-sectional study in China. Diab.\/Metab. Res. Rev. 39(8), e3702 (2023).","journal-title":"Diab.\/Metab. Res. Rev."},{"issue":"3","key":"57284_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S0168-8227(01)00219-4","volume":"52","author":"E Imano","year":"2001","unstructured":"Imano, E. et al. Heart rate elevation and diabetic retinopathy in patients with type 2 diabetes mellitus and normoalbuminuria. Diabetes Res. Clin. Pract. 52(3), 185\u2013191 (2001).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"5","key":"57284_CR35","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/S0272-6386(04)01079-0","volume":"44","author":"RJ Tapp","year":"2004","unstructured":"Tapp, R. J. et al. Albuminuria is evident in the early stages of diabetes onset: results from the Australian diabetes, obesity, and lifestyle study (AusDiab). Am. J. Kidney Dis.: Off. J. Natl. Kidney Found. 44(5), 792\u2013798 (2004).","journal-title":"Am. J. Kidney Dis.: Off. J. Natl. Kidney Found."},{"issue":"1","key":"57284_CR36","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1681\/ASN.2006040394","volume":"18","author":"IH de Boer","year":"2007","unstructured":"de Boer, I. H. et al. Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J. Am. Soc. Nephrology: JASN. 18(1), 235\u2013243 (2007).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"issue":"7448","key":"57284_CR37","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1136\/bmj.38070.450891.FE","volume":"328","author":"P Hovind","year":"2004","unstructured":"Hovind, P. et al. Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study. BMJ (Clinical Res. ed). 328(7448), 1105 (2004).","journal-title":"BMJ (Clinical Res. ed)"},{"issue":"3","key":"57284_CR38","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.diabres.2004.07.021","volume":"67","author":"J Cederholm","year":"2005","unstructured":"Cederholm, J. et al. Microalbuminuria and risk factors in type 1 and type 2 diabetic patients. Diabetes Res. Clin. Pract. 67(3), 258\u2013266 (2005).","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"6","key":"57284_CR39","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1681\/ASN.2005060638","volume":"17","author":"E Ejerblad","year":"2006","unstructured":"Ejerblad, E. et al. Obesity and risk for chronic renal failure. J. Am. Soc. Nephrology: JASN. 17(6), 1695\u20131702 (2006).","journal-title":"J. Am. Soc. Nephrology: JASN"},{"issue":"5","key":"57284_CR40","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","volume":"171","author":"IH de Boer","year":"2011","unstructured":"de Boer, I. H. et al. Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: An analysis of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications cohort. Arch. Intern. Med. 171(5), 412\u2013420 (2011).","journal-title":"Arch. Intern. Med."},{"issue":"7083","key":"57284_CR41","first-page":"783","volume":"314","author":"MA Gall","year":"1997","unstructured":"Gall, M. A. et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study. BMJ (Clinical Res. ed). 314(7083), 783\u2013788 (1997).","journal-title":"BMJ (Clinical Res. ed)"},{"issue":"2","key":"57284_CR42","doi-asserted-by":"publisher","first-page":"108403","DOI":"10.1016\/j.jdiacomp.2023.108403","volume":"37","author":"G Borderie","year":"2023","unstructured":"Borderie, G. et al. Albuminuric diabetic kidney disease predicts foot ulcers in type 2 diabetes. J. Diabetes Complicat. 37(2), 108403 (2023).","journal-title":"J. Diabetes Complicat."},{"key":"57284_CR43","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1159\/000484284","volume":"192","author":"M Mauer","year":"2018","unstructured":"Mauer, M. & Doria, A. Uric acid and diabetic nephropathy risk. Contrib. Nephrol. 192, 103\u2013109 (2018).","journal-title":"Contrib. Nephrol."},{"issue":"5","key":"57284_CR44","doi-asserted-by":"publisher","first-page":"101472","DOI":"10.1016\/j.diabet.2023.101472","volume":"49","author":"YW Cai","year":"2023","unstructured":"Cai, Y. W. et al. Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort. Diabetes Metab. 49(5), 101472 (2023).","journal-title":"Diabetes Metab."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57284-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57284-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:04:03Z","timestamp":1787789043000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-57284-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["57284"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-57284-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"26876"}}